Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.051 AUD | 0.00% |
|
-10.53% | -53.64% |
Jun. 24 | Imugene Doses First Patient of Bile Tract Cancer in Phase One Clinical Trial; Shares Decline 6% | MT |
Apr. 16 | Imugene Signs Deal to Sell Manufacturing Facility For $6 Million | MT |